MSB 2.29% $1.28 mesoblast limited

Ann: Trading Halt, page-195

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,154 Posts.
    lightbulb Created with Sketch. 1197
    IF this is approved I'm going to have look really hard for where I went wrong. I think I'll struggle to see explanations on this forum though. Dachopper seems to have been the only one to try to go through things in technical scientific and statistical depth on the forum.

    What I'll admit I don't properly have a detailed handle on though is the extent to which the FDA could give conditional approval - ie - approval but subject to completion of another trial after approval providing confirmation. Politically that could be tempting to them. But they resisted at ODAC to do what might have been politically easy but scientifically and statistically wrong.

    Its also true I've not seen the detailed datasets that MSB could have provided to the FDA. And which the FDA would be obligated to examine critically and fairly.






 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.28
Change
-0.030(2.29%)
Mkt cap ! $1.461B
Open High Low Value Volume
$1.32 $1.35 $1.28 $1.677M 1.289M

Buyers (Bids)

No. Vol. Price($)
10 44452 $1.28
 

Sellers (Offers)

Price($) Vol. No.
$1.29 23596 1
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.